Full course description
|
Updated terminology: The World Health Organization has renamed "monkeypox" to mpox to reduce stigma and other issues associated with prior terminology. NETEC has made every effort to update materials with the new term. However, some materials, including video recordings and NETEC eLearning Center online courses, are unable to be updated at this time. |
NETEC Webinar Series Presentation
Monkeypox: Updates in Evaluation and Management
Release Date: 09/30/2022
Expires: 09/29/2023
The estimated time to complete this enduring material is 60 minutes.
TARGET AUDIENCE
This accredited continuing education activity is intended primarily for healthcare workers and teams which may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.
EDUCATIONAL OBJECTIVES
At the conclusion of this enduring material, the participant should be better able to:
- Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings
- Describe the clinical presentation in ambulatory and inpatient settings, as well as the role of supportive and antiviral treatments
FACULTY
The faculty have nothing to disclose with the exception of the following:
Jonathan Grein, MD*
Consultant: Parexel International
Speaker: Gilead Sciences
Erica Shenoy, MD, PhD
Consultant/Writer: Up To Date
The below faculty have nothing to disclose:
Kevin Ard, MD, MPH
*Faculty and planning committee member
PLANNING COMMITTEE
The below planning committee members have nothing to disclose:
- Britton Clark, MPH
- Valeta Creason-Wahl, HMCC
- Chimora Imonugo, MD, MPH
- Heidi Keeler, PhD, RN
- Benjamin Mattson, MS Ed
- Jason Noble, BA, BFA
- Aileen Patel, MS, RN, CCR
- Renee Paulin, MSN, RN, CWOCN
- Radu Postelnicu, MD
- Brenda Ram, CMP, CHCP
- Anna Yaffee, MD, MPH
Off-Label Disclosures
Cidofovir, Brincidovofir, and Tecovirimat will be discussed as possible treatments for monkeypox
JYNNEOS vaccination: available under EUA for monkeypox prevention
FINANCIAL SUPPORT
This program is funded by ASPR & CDC